Trichodertna longibmchinturn Rifai aggr. is a fungus reported to be antagonistic to the fungus Mycenn citricolor, the causative agent of the American leaf spot disease of coffee. We have investigated the metabolites produced when ir: kot~gibrnchint~~rn is grown in liquid culture and have isolated several new compounds. The structures of trichodermolide (2) and sorbiquinol(3) were determined by a combination of spectroscopic techniques, including I H and I3c NMR, IR, UV, CD, ORD, and mass spectrometry, and by preparation of derivatives.Key words: Trichodertna lor~gibracl~intwn, leaf spot disease, coffee, fungal metabolites.
RCsum6: Le Triclzodertna lorlgibracllial~~~l Rifai aggr. est un champignon qui serait I'antagoniste du champignon Mycerla citricolo,; I'agent qui serait la cause de la maladie des taches sur les feuilles du cafC amCricain. On a Ctudit les metabolites produits lorsqu'on fait une culture liquide du 7: lorzgibrrrcl~intut~~ et on a isole plusieurs nouveaux composCs. On a dCterminC les structures du trichodermolide (2) et du sorbiquinol(3) par une combinaison de techniques spectroscopiques, y compris la RMN du 'H et du I3c, I'IR, I'UV, le DC, la DRO et la spectromitrie de masse, ainsi qui par la preparation de dtrives.
Two new tetronic acid derivatives, 5-hydroxyvertinolide (1) and
bislongiquinolide (2), have been isolated from the fungus
Trichoderma longibrachiatum Rifai aggr., which is
antagonistic to the fungus Mycena citricolor, the
causative agent of the American leaf spot disease of coffee. The structures
were determined by a combination of spectroscopic techniques, including
1H and 13C n.m.r., i.r., u.v.,
c.d., and mass spectrometry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.